Tetraneuron has developed a gene therapy platform based on E2F4DN, a dominant-negative form of the transcription factor E2F4. According to the company, this is a revolutionary approach, as it acts at ...
Read more
La investigación, publicada en Circulation Research, revela que los neutrófilos, células clave del sistema inmune, modifican su comportamiento según el ritmo circadiano y afectan a la perfusión c...
Read more
The paper describes the case of a patient in whom, years after a bone marrow transplant, two immune cell lines corrected the original genetic defect.
Read more
Demuestran que combinar un medicamento ya aprobado para el tratamiento de la obesidad (Liraglutide) con una nueva molécula creada en Málaga (OLHHA) consigue una mayor reducción del peso corporal y ...
Read more
Los fármacos actuales contra el cáncer de páncreas pierden efectividad en meses porque el tumor se vuelve resistente. El grupo del Centro Nacional de Investigaciones Oncológicas (CNIO) logra evita...
Read more
Overall, the findings position PARG as a potential new therapeutic target in colorectal cancer and open the door to the development of combined strategies integrating PARG inhibition with standard che...
Read more
Científicos andaluces logran una «huella molecular» en glóbulos blancos que ofrece mejoras a ser consideradas en los próximos años
Read more
As every year, World Cancer Day is commemorated on February 4. One of the greatest challenges of modern medicine is finding reliable diagnoses and effective treatments for the different types of cance...
Read more
This is the finding of a multidisciplinary study by Pompeu Fabra University, which has studied in detail the response of lung cancer to immunotherapeutic drugs in experimental treatments with mice.
Read more
A study led by the ITACA Institute shows that AI is helping to improve early diagnosis, advanced monitoring and the prediction of complications in premature newborns or those with serious pathologies....
Read more
Un equipo del CNIO y el CIEMAT elimina las células con un exceso de copias de oncogenes con la técnica de edición genética CRISPR.
Read more
A multidisciplinary Clínic-IDIBAPS team, part of the Clínic Barcelona Comprehensive Cancer Centre (4CB), has published phase 2 results of the CAR-T ARI-0001 (varnimcabtagene autoleucel) for treating...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it a...
